Merck's at-home antiviral COVID-19 pill gets U.S. authorisation

Molnupiravir was shown to reduce hospitalisations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness

source https://www.thehindu.com/sci-tech/health/mercks-at-home-antiviral-covid-19-pill-gets-us-authorisation/article38023837.ece